Medtronic plc Files 8-K on Financials and Senior Notes

Ticker: MDT · Form: 8-K · Filed: 2024-11-19T00:00:00.000Z

Sentiment: neutral

Topics: debt, financials, notes

TL;DR

Medtronic dropped an 8-K detailing its debt maturities and interest rates on senior notes.

AI Summary

On November 19, 2024, Medtronic plc filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior notes due in the coming years, such as those maturing in 2025, 2027, 2028, 2029, and 2031, with varying interest rates.

Why It Matters

This filing provides investors with an update on Medtronic's financial structure, specifically concerning its outstanding debt obligations, which can impact its financial health and future investment decisions.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.

Key Numbers

Key Players & Entities

FAQ

What specific interest rates are associated with the senior notes maturing in 2025?

The filing mentions senior notes due in 2025 with rates of A0.250%, A0.000%, and A2.625%.

Are there any new debt issuances mentioned in this 8-K filing?

This filing primarily details existing senior notes and their maturity dates and interest rates, rather than new issuances.

What is the fiscal year end for Medtronic plc?

Medtronic plc's fiscal year ends on 0425.

What is the accession number for this 8-K filing?

The accession number for this filing is 0001613103-24-000162.

What are the maturity dates for the senior notes with interest rates of A3.650% and A1.625%?

The senior notes with an interest rate of A3.650% mature in 2029, and those with an interest rate of A1.625% mature in 2031.

From the Filing

0001613103-24-000162.txt : 20241119 0001613103-24-000162.hdr.sgml : 20241119 20241119064638 ACCESSION NUMBER: 0001613103-24-000162 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20241119 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241119 DATE AS OF CHANGE: 20241119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 0425 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 241473350 BUSINESS ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: 1 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: 1 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K 1 mdt-20241119.htm 8-K mdt-20241119 0001613103 H91 VY19 false 0001613103 2024-11-19 2024-11-19 0001613103 us-gaap:CommonStockMember 2024-11-19 2024-11-19 0001613103 mdt:A0.250SeniorNotesDue2025Member 2024-11-19 2024-11-19 0001613103 mdt:A0.000SeniorNotesDue2025Member 2024-11-19 2024-11-19 0001613103 mdt:A2.625SeniorNotesDue2025Member 2024-11-19 2024-11-19 0001613103 mdt:A1.125SeniorNotesDue2027Member 2024-11-19 2024-11-19 0001613103 mdt:A0.375SeniorNotesDue2028Member 2024-11-19 2024-11-19 0001613103 mdt:A3.000SeniorNotesDue2028Member 2024-11-19 2024-11-19 0001613103 mdt:A3.650SeniorNotesDue2029Member 2024-11-19 2024-11-19 0001613103 mdt:A1.625SeniorNotesDue2031Member 2024-11-19 2024-11-19 0001613103 mdt:A1.000SeniorNotesDue2031Member 2024-11-19 2024-11-19 0001613103 mdt:A3.125SeniorNotesDue2031Member 2024-11-19 2024-11-19 0001613103 mdt:A0.750SeniorNotesDue2032Member 2024-11-19 2024-11-19 0001613103 mdt:A3.375SeniorNotesDue2034Member 2024-11-19 2024-11-19 0001613103 mdt:A3.875SeniorNotesDue2036Member 2024-11-19 2024-11-19 0001613103 mdt:A2.250SeniorNotesDue2039Member 2024-11-19 2024-11-19 0001613103 mdt:A1.500SeniorNotesDue2039Member 2024-11-19 2024-11-19 0001613103 mdt:A1.375SeniorNotesDue2040Member 2024-11-19 2024-11-19 0001613103 mdt:A4.150SeniorNotesDue2043Member 2024-11-19 2024-11-19 0001613103 mdt:A1.750SeniorNotesDue2049Member 2024-11-19 2024-11-19 0001613103 mdt:A1.625SeniorNotesDue2050Member 2024-11-19 2024-11-19 0001613103 mdt:A4.150SeniorNotesDue2053Member 2024-11-19 2024-11-19 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   _____________________________  FORM 8-K   _____________________________  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2024   _____________________________  Medtronic plc (Exact name of Registrant as Specified in its Charter)    _____________________________    Ireland   1-36820   98-1183488 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) Building Two Parkmore Business Park West Galway , Ireland (Address of principal executive offices) (Zip Code) + 353 1 438-1700 (Registrant’s telephone number, including area code) Not Applicable Former name or former address, if changed since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant t

View on Read The Filing